Stockscreener 앱 받기
3.90
0.76%
-0.03
시간 외 거래:
3.92
0.02
+0.51%
전일 마감가:
$3.93
열려 있는:
$3.99
하루 거래량:
780.94K
Relative Volume:
0.54
시가총액:
$387.38M
수익:
$58.36M
순이익/손실:
$-25.72M
주가수익비율:
-10.71
EPS:
-0.3641
순현금흐름:
$-24.91M
1주 성능:
+2.09%
1개월 성능:
+5.98%
6개월 성능:
+31.76%
1년 성능:
+18.54%
1일 변동 폭
$3.85
$3.99
1주일 범위
$3.83
$4.065
52주 변동 폭
$2.12
$5.80
Aquestive Therapeutics Inc Stock (AQST) Company Profile
명칭
Aquestive Therapeutics Inc
전화
908-941-1900
주소
30 TECHNOLOGY DRIVE, WARREN, NJ
AQST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AQST
Aquestive Therapeutics Inc
|
3.90 | 396.32M | 58.36M | -25.72M | -24.91M | -0.3641 |
|
ZTS
Zoetis Inc
|
147.35 | 64.93B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.44 | 45.07B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.54 | 41.53B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.37 | 18.37B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
301.50 | 13.68B | 2.99B | 1.21B | 1.13B | 25.06 |
Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2024-12-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-05-10 | 개시 | Leerink Partners | Outperform |
| 2024-04-11 | 개시 | Piper Sandler | Overweight |
| 2024-03-28 | 개시 | Raymond James | Outperform |
| 2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
| 2019-04-22 | 개시 | H.C. Wainwright | Buy |
| 2019-01-03 | 개시 | Lake Street | Buy |
| 2018-08-20 | 개시 | JMP Securities | Mkt Outperform |
| 2018-08-20 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Aquestive Therapeutics Inc 주식(AQST)의 최신 뉴스
Uncovering Potential: Aquestive Therapeutics's Earnings Preview - 富途牛牛
Aquestive Therapeutics Inc (AQST) Q2 2025 Earnings Report Preview: What To Expect - Yahoo Finance
What caused AQST's surprising Q2 2024 EPS surge? - AInvest
Aquestive Therapeutics to Report Second Quarter 2025 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET - The Manila Times
Why is Aquestive Therapeutics Inc. stock attracting strong analyst attentionInvest confidently with real-time data analysis - Jammu Links News
What is the risk reward ratio of investing in Aquestive Therapeutics Inc. stockTrack top-performing stocks in real-time - Jammu Links News
What makes Aquestive Therapeutics Inc. stock price move sharplyAccelerated investment success - Jammu Links News
How does Aquestive Therapeutics Inc. compare to its industry peersCapitalize on market momentum for maximum gains - Jammu Links News
What institutional investors are buying Aquestive Therapeutics Inc. stockDiscover breakthrough investment opportunities - Jammu Links News
What drives Aquestive Therapeutics Inc. stock priceCapitalize on market momentum for maximum gains - Jammu Links News
What is the dividend policy of Aquestive Therapeutics Inc. stockInvest confidently with data-driven strategies - Jammu Links News
What analysts say about Aquestive Therapeutics Inc. stockMaximize your portfolio’s growth potential - Jammu Links News
How strong is Aquestive Therapeutics Inc. company’s balance sheetExceptional market performance - Jammu Links News
What are the latest earnings results for Aquestive Therapeutics Inc.Unlock powerful stock screening tools today - Jammu Links News
What are Aquestive Therapeutics Inc. company’s key revenue driversCapitalize on emerging investment opportunities - Jammu Links News
What are the technical indicators suggesting about Aquestive Therapeutics Inc.Unlock powerful market trend analysis - Jammu Links News
Should I hold or sell Aquestive Therapeutics Inc. stock in 2025Significant capital appreciation - Jammu Links News
Aquestive Therapeutics Faces Regulatory Challenges with '5050Item' - AInvest
Is Aquestive Therapeutics Inc. stock overvalued or undervaluedPost Market Guidance For Smart Trading - Jammu Links News
Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) 39% Share Price Surge Not Quite Adding Up - 富途牛牛
Aquestive Therapeutics Inc expected to post a loss of 17 cents a shareEarnings Preview - TradingView
Aquestive Therapeutics Faces Potential Risks with ‘5050Item’: What Investors Need to Know - TipRanks
Investors Hope for Bounce in Aquestive Therapeutics Inc. After SelloffAI Based High Gain Watchlist Scanner Shared - beatles.ru
Strategies to average down on Aquestive Therapeutics Inc.Stock Selection With High Accuracy Based on Models - metal.it
Why Aquestive Therapeutics Inc. is moving todayReal-Time Trade Insights Spark Market Reactions - metal.it
Why Aquestive Therapeutics Inc. stock attracts strong analyst attentionAI Forecast Accuracy Evaluation Forecast - beatles.ru
Published on: 2025-07-29 20:47:23 - beatles.ru
Published on: 2025-07-29 19:03:19 - beatles.ru
Aquestive's Anaphylm to be reviewed by Health Canada - MSN
Published on: 2025-07-29 10:12:06 - metal.it
Published on: 2025-07-29 04:40:45 - metal.it
Published on: 2025-07-28 23:49:46 - metal.it
Is Aquestive Therapeutics Inc. a growth stock or a value stockSmart Portfolio Recommendation For Beginners - Jammu Links News
How does Aquestive Therapeutics Inc. generate profit in a changing economyOutperformance with explosive growth - Jammu Links News
How Efficient Is Aquestive Therapeutics Inc. at Controlling Operating CostsBreakout Confirmation Tool - metal.it
Buy Signal for Aquestive Therapeutics Inc. Stock Key Technical Indicators to WatchFree Access to Community with 300% Return - beatles.ru
Aquestive Therapeutics Inc (AQST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.43%
0.47%
자본화:
|
볼륨(24시간):